10+ can't-miss Houston business and innovation events for September

where to be

Here are over 10 can't-miss events for Houston innovators in September. Photo via Getty Images

From energized tech conferences to informative speaker series, September is filled with opportunities for Houston innovators. Here's a roundup of events you won't want to miss out on so mark your calendars and register accordingly.

Go ahead and add the Houston Innovation Awards on November 14 to your agenda as well — and submit a nomination of a deserving Houston startup or innovator online.

Note: This post may be updated to add more events.

September 4-5 — EcoEngineers' Life-Cycle Analysis Academy

A life-cycle analysis (LCA) is a systematic and comprehensive method for evaluating the environmental impact of a product, service, or system from its inception to its end-of-life.

EcoEngineers has performed more than 1,000 carbon LCAs since 2015 and will guide attendees through the leading industry trends and regulations impacting LCAs. The LCA Academy provides an opportunity for industry leaders and practitioners across all sectors to gain hands on experience in a workshop environment.

This event is Wednesday, September 4, and Thursday, September 5, from 8 am to 5 pm at Petroleum Club. Click here to register.

September 5 — Leading Successful Projects: Managing Risk and Uncertainty with New Technology Implementations

Join RCEL at the Ion for an informative discussion on managing risk and uncertainty in new technology projects. Register to attend and enjoy refreshments, along with an opportunity for networking and discussion following a seminar on navigating risks and uncertainties in new technology applications.

During this seminar, Dr. Claudia Zettner, a Rice University professor will provide real-world examples of new technology implementations and how realized risks affected overall project outcomes.

This event is on Thursday, September 5, from 4 to 5:30 pm at the Ion. Click here to register.

September 9-13 — Houston Energy and Climate Startup Week

Greentown Labs, Halliburton Labs, and The Rice Alliance for Technology and Entrepreneurship are joining forces to launch the inaugural Houston Climate and Energy Startup Week 2024. This week will bring together leading energy and climate investors, industry leaders, and startups from across the globe to showcase and discuss innovative and promising companies and technologies that are transforming the energy industry and driving a sustainable, low-carbon energy future.

This event begins Monday, September 9, at 3:30 pm and runs through, Friday, September 13. Click here for the full schedule and to register.

September 9-13 — Houston Energy and Climate Week

Allies in Energy, a 501c3 non-profit, was formed in Texas to address energy education and climate literacy, and will be hosting their inaugural Houston Energy & Climate Week. This week brings together major cities in creating the national conversations and actions around a net zero future and Houston's leading role in driving solutions. The program themes are energy, innovation, industry, food, environmental justice, health, finance, workforce, community engagement, and policy.

This event begins Monday, September 9, at 7 am and runs through September 13. Click here for the full schedule and to register.

September 11 — Houston Methodist Clinician Speaker Series - Dr. Jordan Dale

Houston Methodist's next clinician speaker is Dr. Jordan Dale, the chief medical information officer. Dale will speak about digital transformation at Houston Methodist, the role of artificial intelligence in healthcare, and the importance of responsible AI use.

This event is Wednesday, September 11, from 4:45 to 6 pm at the Ion. Click here to register.

September 12 — Future of Automated Science Symposium

The Future of Automated Science Symposium is the inaugural annual event focused on automated science. As a new and emerging field, bringing together AI, infrastructure at scale, and high-throughput experimentation, Automated Science can offer new paradigms for scientific investigation.

Hear from academic and industry leaders from Carnegie Mellon University, Emerald Cloud Lab, and Opentrons. Learn about the exciting future of Automated Science and network with like-minded scientists and engineers.

This event is on Thursday, September 12, from 8:30 am to 4:15 pm at TMC Helix Park. Click here to register.

September 13 — 17th Annual Advances in Neurology Symposium

There have been significant advances in the diagnosis and treatment of many neurological diseases. Attempts to cover these scientific advances have been made through peer-reviewed journals, national and international society meetings, and consensus statements. This program will emphasize evidence-based strategy for the current treatment of neurological disorders and cutting-edge research in novel therapeutics.

This event is on Friday, September 13, from 8 am to 5:15 pm at Houston Methodist Research Institute. Click here to register.

September 17-20 — Gastech Conference

The Gastech Conference is an essential forum for energy professionals to shape the future of the industry. It sets the industry's critical agenda by driving energy security and transitions. More than 1,000 speakers will discuss the real-world strategies and business models that deliver energy security, shape climate actions for industry-wide decarbonization, and support a sustainable, affordable, and reliable multi-faceted energy system.

This event begins Tuesday, September 17 at 10 am and runs through Friday September 20 at George R. Brown Convention Center. Click here for the full schedule and to register.

September 19 — Carbon to Value Initiative Year 4 Kickoff

The Carbon to Value (C2V) Initiative is a multi-year collaboration between The Urban Future Lab (UFL), Greentown Labs, and Fraunhofer USA. This partnership is driving the creation of a thriving innovation ecosystem for the commercialization of carbontech—technologies that capture, convert and store carbon dioxide (CO₂) into valuable end products or services.

Celebrate the kickoff of Year 4 of the Carbon to Value Initiative, meet the startups that were selected for this year’s cohort, and hear from industry experts.

This event is on Thursday, September 19, from 5:30 pm to 8 pm at Greentown Labs. Click here to register.

September 24 — TMC Cappucino Connections

Mingle with the Texas Medical Center community and learn about exciting upcoming projects while enjoying complimentary cups of coffee.

This event is on Tuesday, September 24 from 8:30 to 10:30 am at TMC Innovation Factory. Click here to register.

September 25-27 — Innovation for Day One

Innovation for Day One is a conference organized by the Rice360 Institute for Global Health Technologies and the maternal newborn health community to explore groundbreaking tools and approaches for healthy outcomes for mothers and babies in resource-limited communities.

This event is from Wednesday, September 25 through Friday, September 27, at the Bioscience Research Collaborative on Rice University's campus. Click here to register.


Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Greentown Labs names Lawson Gow as its new Houston leader

head of hou

Greentown Labs has named Lawson Gow as its Head of Houston.

Gow is the founder of The Cannon, a coworking space with seven locations in the Houston area, with additional partner spaces. He also recently served as managing partner at Houston-based investment and advisory firm Helium Capital. Gow is the son of David Gow, founder of Energy Capital's parent company, Gow Media.

According to Greentown, Gow will "enhance the founder experience, cultivate strategic partnerships, and accelerate climatetech solutions" in his new role.

“I couldn’t be more excited to join Greentown at this critical moment for the energy transition,” Gow said in a news release. “Greentown has a fantastic track record of supporting entrepreneurs in Houston, Boston, and beyond, and I am eager to keep advancing our mission in the energy transition capital of the world.”

Gow has also held analyst, strategy and advising roles since graduating from Rice University.

“We are thrilled to welcome Lawson to our leadership team,” Georgina Campbell Flatter, CEO of Greentown Labs, added in the release. “Lawson has spent his career building community and championing entrepreneurs, and we look forward to him deepening Greentown’s support of climate and energy startups as our Head of Houston.”

Gow is the latest addition to a series of new hires at Greentown Labs following a leadership shakeup.

Flatter was named as the organization's new CEO in February, replacing Kevin Dutt, Greentown’s interim CEO, who replaced Kevin Knobloch after he announced that he would step down in July 2024 after less than a year in the role.

Greentown also named Naheed Malik its new CFO in January.

Timmeko Moore Love was named the first Houston general manager and senior vice president of Greentown Labs. According to LinkedIn, she left the role in January.

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Houston foundation grants $27M to support Texas chemistry research

fresh funding

Houston-based The Welch Foundation has doled out $27 million in its latest round of grants for chemical research, equipment and postdoctoral fellowships.

According to a June announcement, $25.5 million was allocated for the foundation's longstanding research grants, which provide $100,000 per year in funding for three years to full-time, regular tenure or tenure-track faculty members in Texas. The foundation made 85 grants to faculty at 16 Texas institutions for 2025, including:

  • Michael I. Jacobs, assistant professor in the chemistry and biochemistry department at Texas State University, who is investigating the structure and thermodynamics of intrinsically disordered proteins, which could "reveal clues about how life began," according to the foundation.
  • Kendra K. Frederick, assistant professor in the biophysics department at The University of Texas Southwestern Medical Center, who is studying a protein linked to Parkinson’s disease.
  • Jennifer S. Brodbelt, professor in chemistry at The University of Texas at Austin, who is testing a theory called full replica symmetry breaking (fullRSB) on glass-like materials, which has implications for complex systems in physics, chemistry and biology.

Additional funding will be allocated to the Welch Postdoctoral Fellows of the Life Sciences Research Foundation. The program provides three-year fellowships to recent PhD graduates to support clinical research careers in Texas. Two fellows from Rice University and Baylor University will receive $100,000 annually for three years.

The Welch Foundation also issued $975,000 through its equipment grant program to 13 institutions to help them develop "richer laboratory experience(s)." The universities matched funds of $352,346.

Since 1954, the Welch Foundation has contributed over $1.1 billion for Texas-nurtured advancements in chemistry through research grants, endowed chairs and other chemistry-related ventures. Last year, the foundation granted more than $40.5 million in academic research grants, equipment grants and fellowships.

“Through funding basic chemical research, we are actively investing in the future of humankind,” Adam Kuspa, president of The Welch Foundation, said the news release. “We are proud to support so many talented researchers across Texas and continue to be inspired by the important work they complete every day.”

New Houston biotech co. developing capsules for hard-to-treat tumors

biotech breakthroughs

Houston company Sentinel BioTherapeutics has made promising headway in cancer immunotherapy for patients who don’t respond positively to more traditional treatments. New biotech venture creation studio RBL LLC (pronounced “rebel”) recently debuted the company at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Rima Chakrabarti is a neurologist by training. Though she says she’s “passionate about treating the brain,” her greatest fervor currently lies in leading Sentinel as its CEO. Sentinel is RBL’s first clinical venture, and Chakrabarti also serves as cofounder and managing partner of the venture studio.

The team sees an opportunity to use cytokine interleukin-2 (IL-2) capsules to fight many solid tumors for which immunotherapy hasn't been effective in the past. “We plan to develop a pipeline of drugs that way,” Chakrabarti says.

This may all sound brand-new, but Sentinel’s research goes back years to the work of Omid Veiseh, director of the Rice Biotechnology Launch Pad (RBLP). Through another, now-defunct company called Avenge Bio, Veiseh and Paul Wotton — also with RBLP and now RBL’s CEO and chairman of Sentinel — invested close to $45 million in capital toward their promising discovery.

From preclinical data on studies in mice, Avenge was able to manufacture its platform focused on ovarian cancer treatments and test it on 14 human patients. “That's essentially opened the door to understanding the clinical efficacy of this drug as well as it's brought this to the attention of the FDA, such that now we're able to continue that conversation,” says Chakrabarti. She emphasizes the point that Avenge’s demise was not due to the science, but to the company's unsuccessful outsourcing to a Massachusetts management team.

“They hadn't analyzed a lot of the data that we got access to upon the acquisition,” explains Chakrabarti. “When we analyzed the data, we saw this dose-dependent immune activation, very specific upregulation of checkpoints on T cells. We came to understand how effective this agent could be as an immune priming agent in a way that Avenge Bio hadn't been developing this drug.”

Chakrabarti says that Sentinel’s phase II trials are coming soon. They’ll continue their previous work with ovarian cancer, but Chakrabarti says that she also believes that the IL-2 capsules will be effective in the treatment of endometrial cancer. There’s also potential for people with other cancers located in the peritoneal cavity, such as colorectal cancer, gastrointestinal cancer and even primary peritoneal carcinomatosis.

“We're delivering these capsules into the peritoneal cavity and seeing both the safety as well as the immune activation,” Chakrabarti says. “We're seeing that up-regulation of the checkpoint that I mentioned. We're seeing a strong safety signal. This drug was very well-tolerated by patients where IL-2 has always had a challenge in being a well-tolerated drug.”

When phase II will take place is up to the success of Sentinel’s fundraising push. What we do know is that it will be led by Amir Jazaeri at MD Anderson Cancer Center. Part of the goal this summer is also to create an automated cell manufacturing process and prove that Sentinel can store its product long-term.

“This isn’t just another cell therapy,” Chakrabarti says.

"Sentinel's cytokine factory platform is the breakthrough technology that we believe has the potential to define the next era of cancer treatment," adds Wotton.

View All Listings